144 related articles for article (PubMed ID: 9818079)
41. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
[TBL] [Abstract][Full Text] [Related]
42. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
Sweetenham JW; Mead GM; Whitehouse JM
J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
[TBL] [Abstract][Full Text] [Related]
43. Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Palmieri G; Morabito A; Rea A; Biondi E; Lauria R; Matano E; Pagliarulo C; Montesarchio V; Tagliaferri P; Bianco AR
Int J Oncol; 1998 Jul; 13(1):121-7. PubMed ID: 9625813
[TBL] [Abstract][Full Text] [Related]
44. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
[TBL] [Abstract][Full Text] [Related]
45. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Martelli M; Gherlinzoni F; De Renzo A; Zinzani PL; De Vivo A; Cantonetti M; Falini B; Storti S; Meloni G; Rizzo M; Molinari AL; Lauria F; Moretti L; Lauta VM; Mazza P; Guardigni L; Pescarmona E; Pileri SA; Mandelli F; Tura S
J Clin Oncol; 2003 Apr; 21(7):1255-62. PubMed ID: 12663712
[TBL] [Abstract][Full Text] [Related]
46. [NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Kohda K; Tsuji A; Takayanagi N; Takeda M; Hayashi S; Takimoto R; Fujisaki Y; Tsuji Y; Ezoe A; Nakazawa O
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2183-9. PubMed ID: 7694548
[TBL] [Abstract][Full Text] [Related]
47. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation.
Liu X; Deng T; Guo X; Guo Y; Wang L; Zhang J; Xia Z; Zhang Q; Xue K; Cao J; Shi J; Hong X
Hematology; 2017 Jun; 22(5):258-264. PubMed ID: 27884092
[TBL] [Abstract][Full Text] [Related]
48. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.
Klimo P; Connors JM
Ann Intern Med; 1985 May; 102(5):596-602. PubMed ID: 2580468
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
50. Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.
Schürmann D; Grünewald T; Weiss R; Jautzke G; Pohle HD; Ruf B
Eur J Haematol; 1995 Feb; 54(2):73-7. PubMed ID: 7535244
[TBL] [Abstract][Full Text] [Related]
51. Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B).
Sawada U; Yamazaki T; Suzuki K; Ashiya M; Satou Y; Hirano H; Tsuboi I; Sakuma A; Kura Y; Kouda K
Int J Hematol; 1992 Aug; 56(1):59-66. PubMed ID: 1382663
[TBL] [Abstract][Full Text] [Related]
52. MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study.
Vitolo U; Bertini M; Brusamolino E; Cavallero GB; Comotti B; Gallo E; Ghio R; Levis A; Luxi G; Meneghini V
J Clin Oncol; 1992 Feb; 10(2):219-27. PubMed ID: 1370690
[TBL] [Abstract][Full Text] [Related]
53. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
Gianni AM; Bregni M; Siena S; Brambilla C; Di Nicola M; Lombardi F; Gandola L; Tarella C; Pileri A; Ravagnani F; Valagussa P; Bonadonna G
N Engl J Med; 1997 May; 336(18):1290-7. PubMed ID: 9113932
[TBL] [Abstract][Full Text] [Related]
54. ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Federico M; Moretti G; Gobbi PG; Avanzini P; Cavanna L; Carotenuto M; Lombardo M; Leone G; Pitini V; Abbadessa V
Leukemia; 1991; 5 Suppl 1():95-101. PubMed ID: 1716340
[TBL] [Abstract][Full Text] [Related]
55. R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Shah NN; Szabo A; Huntington SF; Epperla N; Reddy N; Ganguly S; Vose J; Obiozor C; Faruqi F; Kovach AE; Costa LJ; Xavier AC; Okal R; Kanate AS; Ghosh N; Kharfan-Dabaja MA; Strelec L; Hamadani M; Fenske TS; Calzada O; Cohen JB; Chavez J; Svoboda J
Br J Haematol; 2018 Feb; 180(4):534-544. PubMed ID: 29265182
[TBL] [Abstract][Full Text] [Related]
56. [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].
Schneider T; Tóth E; Lovey J; Molnár Z; Deák B; Várady E; Csomor J; Matolcsy A; Lengyel Z; Petri K; Gaudi I; Rosta A
Orv Hetil; 2011 May; 152(19):735-42. PubMed ID: 21498163
[TBL] [Abstract][Full Text] [Related]
57. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
58. MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients.
Derenzini E; Fina MP; Stefoni V; Pellegrini C; Venturini F; Broccoli A; Gandolfi L; Pileri S; Fanti S; Lopci E; Castellucci P; Agostinelli C; Baccarani M; Zinzani PL
Ann Oncol; 2010 Jun; 21(6):1173-1178. PubMed ID: 19861578
[TBL] [Abstract][Full Text] [Related]
59. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
[No Abstract] [Full Text] [Related]
60. MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.
Tarella C; Gallo E; Ferrero D; Badoni R; Carlesso N; Caracciolo D; Pileri A
Haematologica; 1990; 75(2):149-54. PubMed ID: 1694155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
